Open AccessComparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India
Author(s) -
V. Vijayakumar,
Subhadra Nandakumar,
S. Saravanan,
Suresh Jadhav,
Prasad S. Kulkarni,
Sadras Panchatcharam Thyagarajan
Publication year - 2007
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v13.i22.3084
Subject(s) - medicine , hbsag , hepatitis b , hepatitis b vaccine , group b , hepatitis b virus , immunogenicity , seroconversion , vaccination , titer , regimen , pediatrics , gastroenterology , immunology , antibody , virus
To evaluate a low cost Indian recombinant hepatitis B vaccine GeneVac-B for its immunogenicity and safety in comparison to Engerix B and Shanvac B vaccine in high risk newborn infants born to hepatitis B surface antigen (HBsAg) positive mothers.